On 2022-08-18, Clarus Therapeutics Holdings, Inc. (CRXTQ) announced earnings per share of $-0.24 for the fiscal quarter ending 2022-06-30, beating the average analyst estimate of $-0.32.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2022-08-18 | 2022-06-30 | $-0.32 | $-0.24 |
| 2022-05-16 | 2022-03-31 | -- | $-0.61 |
| 2022-03-30 | 2021-12-31 | $-0.47 | $-0.41 |
| 2021-11-18 | 2021-09-30 | $-0.81 | $-0.53 |